| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr3_0366000 | Intergenic-Intergenic | chr3:171854664-171855093 | chr3:172136874-172137303 | 430 nt | 0.4349 |
| hsa_chr3_0366100 | Intergenic-Intergenic | chr3:171855849-171858065 | chr3:172138059-172140275 | 2217 nt | 0.3753 |
| hsa_FNDC3B_0011000 | Intron-Intron | chr3:171856230-171856413 | chr3:172138440-172138623 | 184 nt | 0.2446 |
| hsa_FNDC3B_0011100 | Intron-Intron | chr3:171858436-171858626 | chr3:172140646-172140836 | 191 nt | 0.4607 |
| hsa_chr3_0366200 | Intergenic-Intergenic | chr3:171864026-171864672 | chr3:172146236-172146882 | 647 nt | 0.3833 |
| hsa_FNDC3B_0011200 | Intron-Intron | chr3:171868186-171868772 | chr3:172150396-172150982 | 587 nt | 0.3475 |
| hsa_FNDC3B_0011300 | Intron-Intron | chr3:171871436-171876582 | chr3:172153646-172158792 | 108 nt | 0.4537 |
| hsa_FNDC3B_0011400 | Intron-Intron | chr3:171873656-171876582 | chr3:172155866-172158792 | 176 nt | 0.3239 |
| hsa_FNDC3B_0011500 | Intron-Intron | chr3:171873969-171874996 | chr3:172156179-172157206 | 1028 nt | 0.3881 |
| hsa_chr3_0366300 | Intergenic-Intergenic | chr3:171875375-171875562 | chr3:172157585-172157772 | 188 nt | 0.3245 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].